Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences has informed the stock exchanges about a scheduled conference call for analysts and investors on Wednesday, May 20, 2026 at 4:30 PM IST. The call is for discussing the company's Q4 and FY2026 financial results. The company had previously announced that its Board of Directors meeting to consider and approve standalone and consolidated audited financial results for the quarter and year ended March 31, 2026 would be held. This disclosure is made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. Investors can pre-register through Zoom to participate in the earnings call.
This is a routine disclosure under SEBI regulations informing the market about an upcoming earnings discussion. It reflects standard corporate governance practices and provides transparency about when financial results will be discussed. No direct impact on stock price expected as this is a standard procedural announcement.